Article Versions Notes

de Alwis N, Fato BR, Beard S, Binder NK, Kaitu’u-Lino TJ, Onda K, Hannan NJ. Assessment of the Proton Pump Inhibitor, Esomeprazole Magnesium Hydrate and Trihydrate, on Pathophysiological Markers of Preeclampsia in Preclinical Human Models of Disease. International Journal of Molecular Sciences. 2022; 23(17):9533. https://doi.org/10.3390/ijms23179533

de Alwis, Natasha, Bianca R. Fato, Sally Beard, Natalie K. Binder, Tu’uhevaha J. Kaitu’u-Lino, Kenji Onda, and Natalie J. Hannan. 2022. "Assessment of the Proton Pump Inhibitor, Esomeprazole Magnesium Hydrate and Trihydrate, on Pathophysiological Markers of Preeclampsia in Preclinical Human Models of Disease" International Journal of Molecular Sciences 23, no. 17: 9533. https://doi.org/10.3390/ijms23179533

de Alwis, N., Fato, B. R., Beard, S., Binder, N. K., Kaitu’u-Lino, T. J., Onda, K., & Hannan, N. J. (2022). Assessment of the Proton Pump Inhibitor, Esomeprazole Magnesium Hydrate and Trihydrate, on Pathophysiological Markers of Preeclampsia in Preclinical Human Models of Disease. International Journal of Molecular Sciences, 23(17), 9533. https://doi.org/10.3390/ijms23179533